Hvivo Plc

hVIVO plc is a specialist contract research organisation (CRO) focused on conducting human challenge clinical trials. Its core aim is to accelerate the development of vaccines and antivirals by providing highly controlled, real-world infection models. The company supports pharmaceutical and biotechnology firms globally. Operating within the biopharmaceutical and clinical research sectors, hVIVO plc develops and delivers proprietary human challenge studies that simulate infectious disease exposure. This approach allows for faster, more reliable clinical insights, reducing time to market for new therapies. Stay informed on price movements by adding HVO.L to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.